Nevada Cancer Research Foundation (@nevadancorp) 's Twitter Profile
Nevada Cancer Research Foundation

@nevadancorp

Nevada NCORP is a non-profit dedicated to promoting state-of-the-art cancer treatment for patients in our community

ID: 1005162919804456965

linkhttp://sncrf.org calendar_today08-06-2018 19:01:29

32 Tweet

15 Followers

52 Following

Nevada Cancer Research Foundation (@nevadancorp) 's Twitter Profile Photo

Thank you 8 News NOW - KLAS CH. 8 for featuring our mug on #CoffeeCupSalute! Help support #cancerresearch Donate here: sncrf.org/donate/

Nevada Cancer Research Foundation (@nevadancorp) 's Twitter Profile Photo

#ClinicalTrial S1703 asks if a new approach to monitoring treatment in metastatic, HR+, HER2- breast cancer works as well as the usual approach and if it improves patients’ quality of life and lowers costs. #breastcancerawareness #breastcancer #breastcancerresearch #BCSM #cancer

#ClinicalTrial S1703 asks if a new approach to monitoring treatment in metastatic, HR+, HER2- breast cancer works as well as the usual approach and if it improves patients’ quality of life and lowers costs.  #breastcancerawareness #breastcancer #breastcancerresearch #BCSM #cancer
Nevada Cancer Research Foundation (@nevadancorp) 's Twitter Profile Photo

#nvncorp #nevada #breastcancerawareness #pinkoctober #breastcancer #cancerresearch #cancer #metastaticbreastcancer #metastaticbreastcancerawareness #metastaticbreastcancerawarenessday

#nvncorp #nevada #breastcancerawareness #pinkoctober #breastcancer #cancerresearch #cancer #metastaticbreastcancer #metastaticbreastcancerawareness #metastaticbreastcancerawarenessday
Nevada Cancer Research Foundation (@nevadancorp) 's Twitter Profile Photo

Do you have metastatic breast cancer and a new prescription for a CDK4/6 inhibitor? If so, you may be eligible to participate in clinical trial EAQ221CD/CONCURxP. Learn more here: bit.ly/EAQ221CD #breastcancer #cancertreatment #clinicaltrial

Do you have metastatic breast cancer and a new prescription for a CDK4/6 inhibitor? If so, you may be eligible to participate in clinical trial EAQ221CD/CONCURxP.
Learn more here: bit.ly/EAQ221CD
#breastcancer #cancertreatment #clinicaltrial
Nevada Cancer Research Foundation (@nevadancorp) 's Twitter Profile Photo

The S2010 research study is enrolling women with stage 1, 2, or 3 hormone receptor-positive breast cancer. It tests whether monitoring endocrine therapy side effects more often can help reduce these symptoms. #breastcancer #endocrinetherapy #cancertreatment

The S2010 research study is enrolling women with stage 1, 2, or 3 hormone receptor-positive breast cancer. It tests whether monitoring endocrine therapy side effects more often can help reduce these symptoms.
#breastcancer #endocrinetherapy #cancertreatment
Nevada Cancer Research Foundation (@nevadancorp) 's Twitter Profile Photo

#NCORP #cancerawareness #CancerResearch #netcancer #netcancerawareness #carcinoidcancer #carcinoidcancerawareness #stomachcancerawareness #stomachcancer #GastricCancer #GastricCancerAwareness #lungcancer #LungCancerAwarenessMonth #pancreaticcancerawareness #nevada

#NCORP #cancerawareness #CancerResearch #netcancer #netcancerawareness #carcinoidcancer #carcinoidcancerawareness #stomachcancerawareness #stomachcancer #GastricCancer #GastricCancerAwareness #lungcancer #LungCancerAwarenessMonth #pancreaticcancerawareness #nevada